We provide the chemical producing industries with a comprehensive, AI enabled R&D platform to rapidly guide the design and selection of safer compounds.
Our approach combines standardized, high quality phenotypic screens, machine learning and cloud computing to predict potential toxicity risk earlier in R&D, without the use of animals. Earlier identification of toxicity risk supports industry initiatives to improve productivity, accelerate timelines and reduce costs of new chemical development.
Our screens are offered as a service and results are viewed on the cloud (SaaS).
Trusted by 18,000+ teams around the globe
Supporting improved safety, productivity and sustainability
Our comprehensive, AI enabled R&D discovery platform helps provide chemists with a valuable cheminformatic tool to guide the design and selection of safer compounds
We combine machine learning (ML), high content cellular screens and cloud computing to predict human and environmental safety risk, without the use of animals.
Informative translation of complex chemical and biological data
Discard the spreadsheet. Analysis of large compound libraries and associated biological data using spreadsheets takes days, weeks and even months to figure out what it all means. With 3RnD, reduce that process to minutes.
Our high content, phenotypic screens measure multiple biological parameters that define acute toxicity risk for chemicals. Proprietary human cell and zebrafish embryo models use biological fingerprinting and ML to identify acute toxicity and teratogenesis risk. These New Approach Methodologies (NAM’s) represent the next generation of safety risk assessment tools.